Lineage Cell Therapeutics
LCTX
#8743
Rank
C$0.17 B
Marketcap
$0.77
Share price
-1.91%
Change (1 day)
-47.96%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$45.67 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are C$45.67 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$51.72 M-26.31%
2022-12-31C$70.19 M-33.69%
2021-12-31C$0.10 B547.44%
2020-12-31C$16.35 M-11.37%
2019-12-31C$18.44 M43.66%
2018-12-31C$12.84 M13.77%
2017-12-31C$11.28 M-30.38%
2016-12-31C$16.21 M-35.9%
2015-12-31C$25.29 M79.07%
2014-12-31C$14.12 M-14.16%
2013-12-31C$16.45 M202.71%
2012-12-31C$5.43 M22.25%
2011-12-31C$4.44 M15.48%
2010-12-31C$3.85 M53.19%
2009-12-31C$2.51 M-61.78%
2008-12-31C$6.57 M108.22%
2007-12-31C$3.15 M7.83%
2006-12-31C$2.92 M16.72%
2005-12-31C$2.5 M95.42%
2004-12-31C$1.28 M-72.03%
2003-12-31C$4.59 M8.98%
2002-12-31C$4.21 M29.6%
2001-12-31C$3.25 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$40.32 M-11.71%๐Ÿ‡บ๐Ÿ‡ธ USA